Article EMA Thank You EMA finalizes clinical anticancer therapeutic guidance update
Agency IQ
FEBRUARY 2, 2024
Although this requirement is not new, EMA highlights the pathway for qualification of novel methodologies that could result in a letter of support to aid further development or full qualification, which then supports the acceptability of the method for its intended purpose.
40 
Let's personalize your content